Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 2Subcutaneous panniculitis-like T-cell lymphoma 1Skin Neoplasms 1Melanoma, Cutaneous Malignant 1Lymphoma, T-Cell 1Lymphoma, Primary Cutaneous Anaplastic Large Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Keratosis, Actinic 1Immunoblastic Lymphadenopathy 1Enteropathy-Associated T-Cell Lymphoma 1

Interventions

3-ingenyl angelate 42Aminolevulinic Acid 34Imiquimod 29Fluorouracil 23Photochemotherapy 22methyl 5-aminolevulinate 14Gels 12Diclofenac 12Cryotherapy 12tirbanibulin 7Solutions 7BF-200 ALA 6calcipotriene 5Petrolatum 5Ointments 5LEO 43204 5Radiotherapy 4Prilocaine 4Lidocaine 4Therapeutics 3Niacinamide 3Cryosurgery 3Biopsy 31-phenyl-3,3-dimethyltriazene 3Tomography, Optical Coherence 2SR-T100 2Phototherapy 2Imipramine 2Deoxyribonuclease (Pyrimidine Dimer) 2Celecoxib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Keratosis, Actinic × Cholecalciferol × Dermatologic × Clear all
NCT04140292 2022-06-24

Vitamin D Supplementation as a Neoadjuvant for Photodynamic Therapy of Actinic Keratoses

Case Comprehensive Cancer Center

Phase 2 Completed
75 enrolled 8 charts
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡